Published in Blood Weekly, March 27th, 2003
The agreement will generate immediate revenue for Gradipore.
Upon successful completion of the evaluation to the specified requirements of Serologicals, Gradipore and Serologicals will discuss a more extensive commercial agreement for the purification and commercialization of other plasma proteins.
"Mass producing medically-relevant...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.